Literature DB >> 1499649

The effect of hydrochlorothiazide on the enhanced coughing associated with treatment with enalapril.

J Kamei1, Y Kasuya.   

Abstract

The effect of hydrochlorothiazide, a diuretic which is used in the treatment not only of edema but also of hypertension, on coughs associated with treatment with enalapril was studied in guinea pigs. Chronic treatment with enalapril markedly and dose dependently enhanced the number of capsaicin-induced coughs. However, chronic treatment with hydrochlorothiazide significantly reduced the number of coughs associated with enalapril treatment, also in a dose-dependent manner. These results suggest that diuretics might be used to reduce the coughing associated with treatment with inhibitors of angiotensin-converting enzyme in patients with hypertension.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1499649     DOI: 10.1016/0014-2999(92)90243-w

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  4 in total

1.  Comparative study of effects of angiotensin II receptor antagonist, KD3-671, and angiotensin converting enzyme inhibitor, enalaprilat, on cough reflex in guinea pig.

Authors:  H Miyamoto; K Ito; K Ito; S Wakabayashi; H Suzaka; H Matsuo; T Iga; Y Sawada
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2001 Jan-Jun       Impact factor: 2.441

Review 2.  ACE inhibitor-induced cough and bronchospasm. Incidence, mechanisms and management.

Authors:  A Overlack
Journal:  Drug Saf       Date:  1996-07       Impact factor: 5.606

3.  Cough due to ACE inhibitors: a case-control study using automated general practice data.

Authors:  L E Visser; A E Vlug; J van der Lei; B H Stricker
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

4.  Reproducibility of angiotensin converting enzyme inhibitor induced cough: a double-blind randomised study.

Authors:  V Charlon; S Dollow; J Fidel; C Hoglund; T Honkanen; I Kobrin; J McEwan; G McInnes; J R Viskoper; K S Woo
Journal:  Br J Clin Pharmacol       Date:  1995-02       Impact factor: 4.335

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.